MISSION-CJ for Justice-Involved Homeless Veterans (MISSION-CJ)

March 13, 2026 updated by: VA Office of Research and Development

A Randomized Controlled Trial of MISSION-CJ for Justice-Involved Homeless Veterans With Co-Occurring Substance Use and Mental Health Disorders

The purpose of this study is to determine whether Maintaining Independence and Sobriety through Systems Integration, Outreach and Networking - Criminal Justice version (MISSION-CJ) is effective for reducing criminal recidivism and improving other health-related outcomes (substance use, mental health, housing, employment, community integration) among justice-involved, homeless Veterans with a co-occurring substance use and mental health disorder.

Study Overview

Detailed Description

VHA Mental Health Residential Rehabilitation Treatment Programs (MH RRTPs) serve Veterans with an estimated 50% having criminal justice involvement annually. Justice-involved Veterans (JIVs) receive assistance with their addiction and behavioral health needs, but MH RRTP programs do not directly address their antisocial behaviors and cognitions. Furthermore, MH RRTP discharge is a vulnerable transition and no national transitional approach facilitates Veteran's engagement in prosocial community behaviors that sustain MH RRTP gains, ultimately reducing revolving door service use.

Maintaining Independence and Sobriety through Systems Integration, Outreach, and Networking-Criminal Justice version (MISSION-CJ) is a new case manager and peer delivered team-based treatment for JIVs with a co-occurring substance use and mental health disorder (COD). While MISSION-CJ derives in part from an evidence-based treatment for homeless individuals (MISSION), it includes a new conceptual framework and numerous new and differentiating features for a CJ population including: (1) a treatment planning tool focused on criminogenic needs that monitors progress and tunes service delivery elements; (2) a prosocial treatment curriculum; and (3) tools/resources to address JIVs' legal issues. With MISSION-CJ, this study attempts to change the practice paradigm and transform care for JIVs by moving beyond the current model of linking Veterans to VA care and tracking behavioral health outcomes, to a hybrid treatment/linkage approach that addresses criminogenic needs, supports engagement in VA and non-VA care, and targets recidivism as an outcome-the gold standard for CJ research.

Using a Hybrid Type 1 design, this project will test the effectiveness of MISSION-CJ in a three-site RCT (Bedford, Palo Alto, and Little Rock VAs) with JIVs with a COD, admitted to an MH RRTP, and previously arrested and charged and/or released from incarceration in the past 5-years.

Study Type

Interventional

Enrollment (Actual)

134

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arkansas
      • Little Rock, Arkansas, United States, 72205-5484
        • Central Arkansas VHS John L. McClellan Memorial Veterans Hospital, Little Rock, AR
    • California
      • Palo Alto, California, United States, 94304-1207
        • VA Palo Alto Health Care System, Palo Alto, CA
    • Massachusetts
      • Bedford, Massachusetts, United States, 01730-1114
        • VA Bedford HealthCare System, Bedford, MA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • (a) are entering a Mental Health Residential Rehabilitation Treatment Program (MH RRTP)
  • (b) were arrested and charged and/or released from incarceration in the past 5 years
  • (c) have a co-occurring substance use and mental health disorder (COD)

Exclusion Criteria:

  • The only exclusion criterion is being too cognitively impaired to understand the informed-consent process and other study procedures.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MISSION-CJ
Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice version (MISSION-CJ) programming targets co-occurring substance use and mental health disorders and other related health outcomes faced by justice-involved homeless Veterans through assertive outreach, psychoeducation, and linkages to community-based services.
Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice version (MISSION-CJ) programming targets co-occurring substance use and mental health disorders and other related health outcomes faced by justice-involved homeless Veterans through assertive outreach, psychoeducation, and linkages to community-based services. Patients will receive 2 hours of MISSION-CJ services per week during and after their stay in the mental health residential rehabilitation program (total of 6-months). Services are delivered using a Critical Time Intervention stepdown approach.
Other Names:
  • MISSION-CJ
Experimental: Enhanced Usual Care
Usual care provided by the mental health residential rehabilitation treatment programs, with patients in both groups are enrolled in, in addition to peer support and community outreach case management. Patients receive 2 Peer Support Curriculum sessions per week (24 sessions total). Patients will receive unstructured community outreach and linkage support while enrolled in the mental health residential rehabilitation program. After discharge, patients will continue to receive 1 hour of weekly linkage support per week.
The MISSION Peer Support Curriculum is rolling entry, and includes 24, one-hour exercises focused on co-occurring substance use and mental health disorders, recovery, and community integration.
Other Names:
  • MISSION Peer Support

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Criminal recidivism
Time Frame: through study completion, on average 15-months
Number of arrests based on records from the California and Massachusetts Department of Corrections records; and arrest and incarceration records from the National Crime Information Center.
through study completion, on average 15-months
Criminal recidivism
Time Frame: through study completion, on average 15-months
Number of charges based on records from the California and Massachusetts Department of Corrections records; and arrest and incarceration records from the National Crime Information Center.
through study completion, on average 15-months
Criminal Recidivism
Time Frame: through study completion, on average 15-months
Number of nights in jail or prison based on records from the California and Massachusetts Department of Corrections records; and arrest and incarceration records from the National Crime Information Center.
through study completion, on average 15-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Substance use (Alcohol Use Timeline Follow-back -TLFB)
Time Frame: Baseline, 6-months, 15-months
Quantity of patients' self-reported alcohol use in the past 90 days. Frequency and quantity will be combined to measure alcohol use severity.
Baseline, 6-months, 15-months
Change in Substance use (Alcohol Use Timeline Follow-back -TLFB)
Time Frame: Baseline, 6-months, 15-months
Frequency of patients' self-reported alcohol use in the past 90 days. Frequency and quantity will be combined to measure alcohol use severity.
Baseline, 6-months, 15-months
Change in Substance Use (Illicit Drug Use Timeline Follow back - TLFB)
Time Frame: Baseline, 6-months, 15-months
Quantity of patients' self-reported illicit drug use in the past 90 days. Frequency and quantity will be combined to measure drug use severity.
Baseline, 6-months, 15-months
Change in Substance Use (Illicit Drug Use Timeline Follow back - TLFB)
Time Frame: Baseline, 6-months, 15-months
Frequency of patients' self-reported illicit drug use in the past 90 days. Frequency and quantity will be combined to measure drug use severity.
Baseline, 6-months, 15-months
Change in Trauma Symptoms (PTSD Checklist for DSM-5 - PCL-5)
Time Frame: Baseline, 6-months, 15-months
Changes in the severity of patients' PTSD symptoms. A total severity score is computed by summing all the items. Scores range from 0-80 with higher scores indicating higher severity.
Baseline, 6-months, 15-months
Change in Depression (Patient Health Questionnaire-9 - PHQ-9)
Time Frame: Baseline, 6-months, 15-months
Changes in the degree of depression severity self-reported by patients. Total scores range from 0-27 with higher scores indicating more severe depression.
Baseline, 6-months, 15-months
Change in Mental Health Symptoms (Behavior and Symptom Identification Scale-24 - BASIS-24)
Time Frame: Baseline, 6-months, 15-months
Changes in the severity of patients' self-reported psychiatric symptoms across 6 subscales (e.g. Depression and Functioning, Interpersonal Relationships, Self-Harm, Psychosis, Substance Abuse, and Emotional Lability) during the past week. Patients score items on a scale of 0-4, and each subscale and mean total score range from 0-4, with higher scores indicating higher levels of severity of symptoms.
Baseline, 6-months, 15-months
Change in Recidivism risk (Level of Service Inventory-Revised)
Time Frame: Baseline, 6-months, 15-months
Changes in the severity of patients' self-reported legal problems. Self-reported arrests, charges, and months incarcerated since the baseline assessment. Total LSI-R scores will be used. Scores range from 0-54 with higher scores indicating greater risk.
Baseline, 6-months, 15-months
Change in Medication Adherence Rating Scale (MARS)
Time Frame: Baseline, 6-months, 15-months
Patients' self-reported compliance with medication. Questions are dichotomous yes/no.
Baseline, 6-months, 15-months
Change in Housing Status (Residential Timeline Follow back)
Time Frame: Baseline, 6-months, 15-months
Quantity of patients' self-reported days homeless in the past 90 days.
Baseline, 6-months, 15-months
Change in Housing Status (Residential Timeline Follow back)
Time Frame: Baseline, 6-months, 15-months
Frequency of patients' self-reported days homeless in the past 90 days.
Baseline, 6-months, 15-months
Change in Employment (Maudsley Addiction Profile)
Time Frame: Baseline, 6-months, 15-months
Quantity of days worked, days absent, and days unemployed in the past 30 days, as self-reported by patients since the baseline assessment.
Baseline, 6-months, 15-months
Change in Employment (Maudsley Addiction Profile)
Time Frame: Baseline, 6-months, 15-months
Frequency of days worked, days absent, and days unemployed in the past 30 days, as self-reported by patients since the baseline assessment.
Baseline, 6-months, 15-months
Treatment Engagement (MISSION Treatment Services Tracking Sheet
Time Frame: Up to 12 months
Number of services for both VA and non-VA services received (pre- and post-MH RRTP). This includes all possible services offered within MISSION-CJ and EUC (MISSION Peer Support) as well as community linkages. Regarding linkages, the measure quantifies the number of referrals, referral type, and client engagement. Examine change in number of services received during 12 months, collected on a weekly basis.
Up to 12 months
Treatment Engagement (MISSION Treatment Services Tracking Sheet)
Time Frame: Up to 12 months
Types of services for both VA and non-VA services received (pre- and post-MH RRTP). This includes all possible services offered within MISSION-CJ and Enhanced Usual Care (MISSION Peer Support) as well as community linkages. Examine change in types of services received during 12 months, collected on a weekly basis.
Up to 12 months
Change in Treatment Engagement (Alcoholics Anonymous Involvement Scale - AAI)
Time Frame: Baseline, 6-months, 15-months
Change in patients' self-reported involvement in 12-step groups for substance use. Items are dichotomous yes/no, with yes responses indicating more involvement in 12-step groups. Composite scores range from 0-9 with 9 indicating more involvement in 12-step groups. Patients are also asked to indicate which of the 12-steps they have worked.
Baseline, 6-months, 15-months
Change in Treatment Engagement (Alcoholics Anonymous Involvement Scale - AAI)
Time Frame: Baseline, 6-months, 15-months
Change in patients' self-reported attendance in 12-step groups for substance use over lifetime, and since the previous assessment. Patients report an estimated number of meetings they've attended in the last year, and in their lifetime.
Baseline, 6-months, 15-months
Treatment Engagement (Healthcare Continuing Care Utilization)
Time Frame: 12-month period prior to, and ending 15 months after, study enrollment
Data on SUD/MH continuing care utilization since the prior assessment will be defined as the number of sessions in each setting that the clients attend throughout the follow-up period. Both will be obtained from: (a) CDW, for VA care and (b) service tracking sheets for VA and non-VA health care utilization. For VA care, the electronic medical record data will be obtained from the CDW. CDW data includes both outpatient encounter records (including the type of outpatient care - e.g., from outreach programs, office-based clinical services) and information on inpatient and residential care services used.
12-month period prior to, and ending 15 months after, study enrollment
Treatment Engagement (MH RRTP Completion)
Time Frame: 12-month period prior to, and ending 15 months after, study enrollment
Healthcare utilization includes both VA and non-VA healthcare services and we will construct several measures. MH RRTP completion will be defined as a regular discharge from the program and determined from the VA's Corporate Data Warehouse (CDW).
12-month period prior to, and ending 15 months after, study enrollment
Change in Community Integration Measure (CIM)
Time Frame: Baseline, 6-months, 15-months
Patient's self-report perspective of their integration into their home and community are scored on a 5-point scale. A single summary score (range 10-50) is computed by summing each item, with lower scores indicating
Baseline, 6-months, 15-months
Change in Antisocial Attitudes (Measures of Criminal Attitudes and Associates - MCAA)
Time Frame: Baseline, 6-months, 15-months
Changes in patients' self-report of antisocial attitudes on 4 scales: violence, entitlement, antisocial intent, and associates. Responses to MCAA Part B are dichotomous agree/disagree.
Baseline, 6-months, 15-months
Change in Affiliations with Antisocial Peers (Measures of Criminal Attitudes and Associates: MCAA)
Time Frame: Baseline, 6-months, 15-months
Changes in patients' self-report of criminal associations. Part A of the MCAA is intended to quantify criminal associations. In Part A, respondents are asked to recall the four adults in the community with whom they spend the most free time. For each adult, they then indicate how much of their free time is spent in their associate's company. The respondent then answers four questions regarding the degree of criminal involvement of their associates: (a) Has this person ever committed a crime; (b) Does this person have a criminal record; (c) Has this person ever been to jail? and (d) Has this person tried to involve you in a crime? From this information, a measure of criminal associates can be calculated. The Number of Criminal Friends is calculated by totaling the number of friends for which the respondent answers yes to any of the questions of criminal involvement.
Baseline, 6-months, 15-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Daniel M. Blonigen, PhD MA, VA Palo Alto Health Care System, Palo Alto, CA
  • Principal Investigator: David A. Smelson, PsyD, VA Bedford HealthCare System, Bedford, MA

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2021

Primary Completion (Actual)

February 27, 2026

Study Completion (Actual)

February 28, 2026

Study Registration Dates

First Submitted

July 28, 2020

First Submitted That Met QC Criteria

August 20, 2020

First Posted (Actual)

August 21, 2020

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 13, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Substance Use Disorder

Clinical Trials on Maintaining Maintaining Independence and Sobriety through Systems Integration Outreach and Networking- Criminal Justice

Subscribe